Arthur M. Cohen & Associates LLC lowered its position in Clorox Co (NYSE:CLX) by 5.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,904 shares of the company’s stock after selling 919 shares during the period. Clorox accounts for about 0.8% of Arthur M. Cohen & Associates LLC’s investment portfolio, making the stock its 23rd largest holding. Arthur M. Cohen & Associates LLC’s holdings in Clorox were worth $2,595,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. increased its position in Clorox by 3.2% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 27,406 shares of the company’s stock valued at $4,196,000 after buying an additional 858 shares in the last quarter. Andra AP fonden increased its position in Clorox by 19.4% during the 2nd quarter. Andra AP fonden now owns 47,400 shares of the company’s stock valued at $7,257,000 after buying an additional 7,700 shares in the last quarter. Cetera Advisor Networks LLC increased its position in Clorox by 1.3% during the 3rd quarter. Cetera Advisor Networks LLC now owns 9,627 shares of the company’s stock valued at $1,464,000 after buying an additional 127 shares in the last quarter. Maverick Capital Ltd. bought a new position in Clorox during the 2nd quarter valued at approximately $1,643,000. Finally, SG Americas Securities LLC boosted its stake in Clorox by 94.7% during the 3rd quarter. SG Americas Securities LLC now owns 26,751 shares of the company’s stock valued at $4,063,000 after purchasing an additional 13,008 shares during the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.
CLX has been the topic of several recent analyst reports. Citigroup cut their target price on Clorox from $167.00 to $163.00 and set a “neutral” rating on the stock in a research note on Thursday, October 3rd. UBS Group cut their target price on Clorox from $128.00 to $125.00 and set a “sell” rating on the stock in a research note on Thursday, October 3rd. Bank of America cut their target price on Clorox from $165.00 to $160.00 and set a “neutral” rating on the stock in a research note on Thursday, October 3rd. Deutsche Bank increased their target price on Clorox from $145.00 to $147.00 and gave the company a “hold” rating in a research note on Thursday, December 12th. Finally, Morgan Stanley reiterated an “underweight” rating and set a $134.00 target price (down from $144.00) on shares of Clorox in a research note on Monday, September 30th. Five equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $152.17.
CLX stock opened at $152.80 on Friday. The company has a market cap of $19.07 billion, a P/E ratio of 24.18, a price-to-earnings-growth ratio of 4.86 and a beta of 0.39. Clorox Co has a 1 year low of $143.58 and a 1 year high of $166.90. The company has a debt-to-equity ratio of 4.69, a current ratio of 0.87 and a quick ratio of 0.52. The stock’s fifty day moving average price is $151.01 and its 200-day moving average price is $153.80.
Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, October 31st. The company reported $1.59 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.54 by $0.05. The firm had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.51 billion. Clorox had a return on equity of 123.56% and a net margin of 13.20%. The company’s revenue for the quarter was down 3.6% on a year-over-year basis. During the same period last year, the business posted $1.62 EPS. As a group, analysts expect that Clorox Co will post 6.16 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.06 dividend. The ex-dividend date of this dividend is Tuesday, January 28th. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.77%. Clorox’s dividend payout ratio (DPR) is currently 67.09%.
In related news, SVP Andrew J. Mowery sold 5,648 shares of Clorox stock in a transaction on Monday, November 4th. The stock was sold at an average price of $146.29, for a total transaction of $826,245.92. Following the transaction, the senior vice president now directly owns 15,920 shares in the company, valued at $2,328,936.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Denise Garner sold 725 shares of Clorox stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $146.34, for a total value of $106,096.50. Following the transaction, the senior vice president now owns 5,805 shares in the company, valued at $849,503.70. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: S&P/ASX 200 Index
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.